Correlation Between Eyepoint Pharmaceuticals and Basilea Pharmaceutica
Can any of the company-specific risk be diversified away by investing in both Eyepoint Pharmaceuticals and Basilea Pharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyepoint Pharmaceuticals and Basilea Pharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyepoint Pharmaceuticals and Basilea Pharmaceutica AG, you can compare the effects of market volatilities on Eyepoint Pharmaceuticals and Basilea Pharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyepoint Pharmaceuticals with a short position of Basilea Pharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyepoint Pharmaceuticals and Basilea Pharmaceutica.
Diversification Opportunities for Eyepoint Pharmaceuticals and Basilea Pharmaceutica
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Eyepoint and Basilea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Eyepoint Pharmaceuticals and Basilea Pharmaceutica AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Basilea Pharmaceutica and Eyepoint Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyepoint Pharmaceuticals are associated (or correlated) with Basilea Pharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Basilea Pharmaceutica has no effect on the direction of Eyepoint Pharmaceuticals i.e., Eyepoint Pharmaceuticals and Basilea Pharmaceutica go up and down completely randomly.
Pair Corralation between Eyepoint Pharmaceuticals and Basilea Pharmaceutica
If you would invest 758.00 in Eyepoint Pharmaceuticals on October 26, 2024 and sell it today you would earn a total of 114.00 from holding Eyepoint Pharmaceuticals or generate 15.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyepoint Pharmaceuticals vs. Basilea Pharmaceutica AG
Performance |
| Timeline |
| Eyepoint Pharmaceuticals |
| Basilea Pharmaceutica |
Eyepoint Pharmaceuticals and Basilea Pharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyepoint Pharmaceuticals and Basilea Pharmaceutica
The main advantage of trading using opposite Eyepoint Pharmaceuticals and Basilea Pharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyepoint Pharmaceuticals position performs unexpectedly, Basilea Pharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Basilea Pharmaceutica will offset losses from the drop in Basilea Pharmaceutica's long position.The idea behind Eyepoint Pharmaceuticals and Basilea Pharmaceutica AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |